MicroStrategy
MSTR
Coinbase
COIN
MARA Holdings
MARA
Meta Platforms
META
Alphabet-A
GOOGL
US Stock MarketDetailed Quotes
PDSB PDS Biotechnology
- 1.710
- -0.090-5.00%
Close Jan 6 16:00 ET
- 1.710
- 0.0000.00%
Post 16:00 ET
63.97MMarket Cap-1.46P/E (TTM)
1.820High1.705Low276.79KVolume1.770Open1.800Pre Close484.93KTurnover0.77%Turnover RatioLossP/E (Static)37.41MShares6.68052wk High2.91P/B61.60MFloat Cap1.53052wk Low--Dividend TTM36.02MShs Float17.850Historical High--Div YieldTTM6.39%Amplitude0.615Historical Low1.751Avg Price1Lot Size
About PDS Biotechnology Company
PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its product, PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo in 2005 and is headquartered in Princeton, NJ.
Company Profile
SymbolPDSB
Company NamePDS Biotechnology
Listing DateOct 1, 2015
Issue Price11.00
Founded2005
CEODr. Frank Bedu-Addo, PhD
MarketNASDAQ
Employees25
Fiscal Year Ends12-31
Address303A College Road East
CityPrinceton
ProvinceNew Jersey
CountryUnited States of America
Zip Code08540
Phone1-800-208-3343
Websitehttp://www.pdsbiotech.com
Company Executives
- Name
- Position
- Salary
- Dr. Frank Bedu-Addo, PhD
- Director, President and Chief Executive Officer
- 5.01M
- Lars Boesgaard
- Chief Financial Officer and Principal Accounting Officer
- --
- Stephan F. Toutain, M.B.A.,M.S.
- Chief Operations Officer
- --
- Gregory L. Conn
- Chief Scientific Officer
- 1.68M
- Dr. Kirk V. Shepard, M.D.
- Chief Medical Officer
- --
- Spencer D. Brown
- Senior Vice President, General Counsel and Chief Compliance Officer
- --
- Stephen C. Glover
- Chairman of the Board
- 135.99K
- Dr. Ilian Petkov Iliev
- Director
- 82.99K
- Dr. Otis W. Brawley,M.D.
- Independent Director
- 82.99K
- Sir Richard Brook Sykes
- Independent Director
- 94.49K
- Kamil Ali-Jackson, Esq.
- Independent Director
- 106.49K
- Gregory G. Freitag, C.P.A.,J.D.
- Independent Director
- 105.49K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.